Display options
Cite
Choi J, Kim C, Lee HS, et al. Detection of Human Papillomavirus in Korean Breast Cancer Patients by Real-Time Polymerase Chain Reaction and Meta-Analysis of Human Papillomavirus and Breast Cancer. J Pathol Transl Med. 2016;50(6):442-450doi: 10.4132/jptm.2016.07.08.
Choi, J., Kim, C., Lee, H. S., Choi, Y. J., Kim, H. Y., Lee, J., Chang, H., & Kim, A. (2016). Detection of Human Papillomavirus in Korean Breast Cancer Patients by Real-Time Polymerase Chain Reaction and Meta-Analysis of Human Papillomavirus and Breast Cancer. Journal of pathology and translational medicine, 50(6), 442-450. https://doi.org/10.4132/jptm.2016.07.08
Choi, Jinhyuk, et al. "Detection of Human Papillomavirus in Korean Breast Cancer Patients by Real-Time Polymerase Chain Reaction and Meta-Analysis of Human Papillomavirus and Breast Cancer." Journal of pathology and translational medicine vol. 50,6 (2016): 442-450. doi: https://doi.org/10.4132/jptm.2016.07.08
Choi J, Kim C, Lee HS, Choi YJ, Kim HY, Lee J, Chang H, Kim A. Detection of Human Papillomavirus in Korean Breast Cancer Patients by Real-Time Polymerase Chain Reaction and Meta-Analysis of Human Papillomavirus and Breast Cancer. J Pathol Transl Med. 2016 Nov;50(6):442-450. doi: 10.4132/jptm.2016.07.08. Epub 2016 Oct 10. PMID: 27725620; PMCID: PMC5122727.
Copy Download .nbib Format: NLM
Share it on

J Pathol Transl Med. 2016 Nov;50(6):442-450. doi: 10.4132/jptm.2016.07.08. Epub 2016 Oct 10.

Detection of Human Papillomavirus in Korean Breast Cancer Patients by Real-Time Polymerase Chain Reaction and Meta-Analysis of Human Papillomavirus and Breast Cancer.

Journal of pathology and translational medicine

Jinhyuk Choi, Chungyeul Kim, Hye Seung Lee, Yoo Jin Choi, Ha Yeon Kim, Jinhwan Lee, Hyeyoon Chang, Aeree Kim

Affiliations

  1. Department of Pathology, Korea University Guro Hospital, Seoul, Korea.

PMID: 27725620 PMCID: PMC5122727 DOI: 10.4132/jptm.2016.07.08

Abstract

BACKGROUND: Human papillomavirus (HPV) is a well-established oncogenic virus of cervical, anogenital, and oropharyngeal cancer. Various subtypes of HPV have been detected in 0% to 60% of breast cancers. The roles of HPV in the carcinogenesis of breast cancer remain controversial. This study was performed to determine the prevalence of HPV-positive breast cancer in Korean patients and to evaluate the possibility of carcinogenic effect of HPV on breast.

METHODS: Meta-analysis was performed in 22 case-control studies for HPV infection in breast cancer. A total of 123 breast cancers, nine intraductal papillomas and 13 nipple tissues of patients with proven cervical HPV infection were tested by real-time polymerase chain reaction to detect 28 subtypes of HPV. Breast cancers were composed of 106 formalin-fixed and paraffin embedded (FFPE) breast cancer samples and 17 touch imprint cytology samples of breast cancers.

RESULTS: The overall odds ratio between breast cancer and HPV infection was 5.43 (95% confidence interval, 3.24 to 9.12) with I2 = 34.5% in meta-analysis of published studies with case-control setting and it was statistically significant. HPV was detected in 22 cases of breast cancers (17.9%) and two cases of intaductal papillomas (22.2%). However, these cases had weak positivity.

CONCLUSIONS: These results failed to serve as significant evidence to support the relationship between HPV and breast cancer. Further study with larger epidemiologic population is merited to determine the relationship between HPV and breast cancer.

Keywords: Breast neoplasms; Human papillomavirus; Meta-analysis; Real-time polymerase chain reaction

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

References

  1. PLoS One. 2013 Apr 25;8(4):e61613 - PubMed
  2. PLoS One. 2015 Aug 21;10(8):e0136050 - PubMed
  3. Virol J. 2014 Nov 21;11:190 - PubMed
  4. Chin J Physiol. 2014 Apr 30;57(2):105-6 - PubMed
  5. Med Oncol. 2012 Jun;29(2):521-5 - PubMed
  6. Ecancermedicalscience. 2015 Jun 25;9:548 - PubMed
  7. Int Rev Immunol. 2014 Oct;33(5):383-401 - PubMed
  8. PLoS One. 2014 May 23;9(5):e97787 - PubMed
  9. Adv Biomed Res. 2014 Jan 27;3:75 - PubMed
  10. Breast Cancer Res. 2005;7(1):R1-11 - PubMed
  11. J Clin Virol. 2014 Oct;61(2):255-9 - PubMed
  12. Breast Cancer Res Treat. 2009 Mar;114(1):189-94 - PubMed
  13. J Med Virol. 2013 Dec;85(12):2087-92 - PubMed
  14. J Med Virol. 2015 Jun;87(6):1034-40 - PubMed
  15. Br J Cancer. 2008 Aug 5;99(3):408-14 - PubMed
  16. J Mol Med (Berl). 1997 Jun;75(6):429-39 - PubMed
  17. Mol Biol Rep. 2009 Apr;36(4):807-12 - PubMed
  18. BMC Cancer. 2011 Jan 20;11:27 - PubMed
  19. Med Oncol. 2012 Mar;29(1):48-55 - PubMed
  20. Br J Cancer. 2009 Oct 20;101(8):1345-50 - PubMed
  21. Oncology (Williston Park). 2015 Sep;29(9):616-26 - PubMed
  22. Tumour Biol. 2007;28(6):327-32 - PubMed
  23. Breast. 2007 Apr;16(2):172-7 - PubMed
  24. J Int Med Res. 2011;39(5):1636-44 - PubMed
  25. BMC Cancer. 2013 Oct 01;13:445 - PubMed
  26. Breast Cancer Res Treat. 1999 Jan;53(2):121-35 - PubMed
  27. East Mediterr Health J. 2014 Jun 18;20(6):372-7 - PubMed
  28. ScientificWorldJournal. 2012;2012:837191 - PubMed
  29. Infect Agent Cancer. 2013 Sep 02;8:32 - PubMed
  30. Breast Cancer Res Treat. 2004 Mar;84(2):131-7 - PubMed
  31. PLoS One. 2012;7(11):e48788 - PubMed
  32. Asian Pac J Cancer Prev. 2014;15(9):4061-5 - PubMed
  33. Anticancer Res. 2015 Feb;35(2):851-6 - PubMed
  34. Br J Cancer. 2005 Oct 17;93(8):946-8 - PubMed
  35. Anticancer Res. 1999 Nov-Dec;19(6B):5057-61 - PubMed
  36. J Med Virol. 2005 Feb;75(2):276-81 - PubMed
  37. Pathol Res Pract. 1992 Apr;188(3):384-6 - PubMed
  38. BMC Cancer. 2009 Jan 22;9:26 - PubMed
  39. Br J Cancer. 2008 Aug 5;99(3):404-7 - PubMed
  40. Sultan Qaboos Univ Med J. 2013 Nov;13(4):527-33 - PubMed
  41. Eur J Gynaecol Oncol. 2012;33(2):164-7 - PubMed

Publication Types